Baxter's $4B buyout of Gambro gets OK from Australian regulators

09/6/2013 | MassDevice.com (Boston)

Baxter's acquisition of Gambro, a Swedish maker of dialysis systems, for almost $4 billion has won approval from business regulators in Australia. The decision is contingent on Baxter divesting itself of its renal replacement therapy unit. The acquisition also has the green light from regulators in the U.S., Europe, Canada, Turkey, Ukraine, Brazil, South Korea and China.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA